(Q70159204)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6309981%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Acquired resistance to acyclovir: laboratory phenomenon or clinical problem? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6309981%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Acquired resistance to acyclovir: Laboratory phenomenon or clinical problem? (English)

1 reference

https://api.crossref.org/works/10.1016/S0163-4453(83)94052-5

24 September 2023

1 reference

H. J. Field

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6309981

24 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6309981

24 September 2023

publication date

1 May 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6309981%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

9 October 2019

https://api.elsevier.com/content/article/PII:S0163445383940525?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0163-4453(83)94052-5

https://api.elsevier.com/content/article/PII:S0163445383940525?httpAccept=text/plain

24 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0163-4453(83)94052-5

24 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6309981%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6309981%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

1 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6309981%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

11-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6309981%20AND%20SRC:MED&resulttype=core&format=json

Isolation and Characterization of Acyclovir-resistant Mutants of Herpes Simplex Virus

9 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

The Sensitivity of Acyclovir-Resistant Mutants of Herpes Simplex Virus to Other Antiviral Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

Trigeminal Ganglion Infection by Thymidine Kinase-Negative Mutants of Herpes Simplex Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

Isolation and characterization of acyclovir-resistant strains of herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

Sensitivity of herpes virus isolates from acyclovir clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

Spectrum of sensitivity to acyclovir of herpes simplex virus clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

MUTANT STRAINS OF HERPES SIMPLEX DEFICIENT IN THYMIDINE KINASE-INDUCING ACTIVITY

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

Drug resistance and antiviral agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2994052-5

7 January 2021

Resistance of peripheral autonomic neurons to in vivo productive infection by herpes simplex virus mutants deficient in thymidine kinase activity

series ordinal

8

1 reference

https://api.crossref.org/works/10.1016/S0163-4453(83)94052-5

24 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6309981%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference